Tempus AI raises 2025 revenue outlook again after strong Q2 growth in genomics and AI-driven oncology solutions.

Tempus AI, Inc. Class A (($TEM)) has held its Q2 earnings call. Read on for the main highlights of the call. Tempus AI, Inc. Class A recently held ...

Bioventus Inc. (NASDAQ:BVS) is one of the best medical device stocks to buy according to analysts. On August 7, Craig-Hallum analyst Chase Knickerbocker reiterated a Buy rating on Bioventus Inc.

Ballie Gifford is one of the best growth investors in the world and has been almost form inception. The firm was founded in ...

Laman Ismayilova Read more The Institute of Archaeology and Anthropology has published its first issue of the international ...

Tempus Resources Ltd. ( ($AU:SMM) ) just unveiled an update. Somerset Minerals Limited, a company listed on the Australian Securities Exchange, ...